Cargando…
Small GSK-3 Inhibitor Shows Efficacy in a Motor Neuron Disease Murine Model Modulating Autophagy
Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron degenerative disease that has no effective treatment up to date. Drug discovery tasks have been hampered due to the lack of knowledge in its molecular etiology together with the limited animal models for research. Recently, a motor ne...
Autores principales: | de Munck, Estefanía, Palomo, Valle, Muñoz-Sáez, Emma, Perez, Daniel I., Gómez-Miguel, Begoña, Solas, M. Teresa, Gil, Carmen, Martínez, Ana, Arahuetes, Rosa M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025054/ https://www.ncbi.nlm.nih.gov/pubmed/27631495 http://dx.doi.org/10.1371/journal.pone.0162723 |
Ejemplares similares
-
In Utero Hepatocellular Transplantation in Rats
por: Muñoz-Sáez, Emma, et al.
Publicado: (2013) -
Modulation of GSK-3 provides cellular and functional neuroprotection in the rd10 mouse model of retinitis pigmentosa
por: Sánchez-Cruz, Alonso, et al.
Publicado: (2018) -
Neuronal Apoptosis and Motor Deficits in Mice with Genetic Inhibition of GSK-3 Are Fas-Dependent
por: Gómez-Sintes, Raquel, et al.
Publicado: (2013) -
Multifaceted Roles of GSK-3 in Cancer and Autophagy-Related Diseases
por: Mancinelli, Romina, et al.
Publicado: (2017) -
GSK3B induces autophagy by phosphorylating ULK1
por: Ryu, Hye Young, et al.
Publicado: (2021)